Laboratorio Reig Jofre, S.A. (BME:RJF)

Market Cap	214.11M -8.3%
Revenue (ttm)	337.73M +0.3%
Net Income	6.94M +8.7%
EPS	n/a
Shares Out	81.41M
PE Ratio	30.87
Forward PE	13.15
Dividend	0.05 (1.80%)
Ex-Dividend Date	May 21, 2026

Volume	8,482
Open	2.620
Previous Close	2.630
Day's Range	2.610 - 2.640
52-Week Range	2.320 - 3.350
Beta	0.95
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical devices, cosmetics, parapharmaceuticals, food, and other products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; and food supplements under the For...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1929
• Employees: 1,400
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: RJF

Financial Performance

In 2025, Laboratorio Reig Jofre's revenue was 336.68 million, a decrease of -1.37% compared to the previous year's 341.37 million. Earnings were 5.02 million, a decrease of -51.64%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 16, 2026

Data Sources Report a data error